The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells

Overview of attention for article published in Breast Cancer Research and Treatment, January 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 39 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 4,831 followers.

#breastcancer #HER2 #trastuzumab #imetelstat $GERN -- Promising mechanism of action; combination treatment https://t.co/4HU8u7v7j7

Reply Repost Favourite

Imetelstat Alone, & in Combination w/ Trastuzumab, Decreases the CSC... @IndianaUniv @iumedschool http://t.co/ORakaX1ZID

Reply Repost Favourite

The Telomerase Inhibitor Imetelstat Alone, & in Combination w/ Trastuzumab, Decreases... @IndianaUniv @iumedschool http://t.co/I0XbMWGosY

Reply Repost Favourite

Imetelstat Alone & in Combination with Trastuzumab, Decreases the CSC Population and Self-Renewal of HER2+ BCCs http://t.co/PhwLsjTSG9

Reply Repost Favourite

$GERN HER2+ breast cancer abstract http://t.co/sCrirm5xnn

Reply Repost Favourite